HMIN [Homeinns Hotel] UPLOAD: (Original Filing)
[]
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray Announces Second Quarter 2012 Financial Results Shenzhen, China August 6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million, an increase of 23.3%]
MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2012 Financial Results Shenzhen,
[Mindray Announces Second Quarter 2012 Financial Results Shenzhen, China August 6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million, an increase of 23.3%]
YGE [YINGLI GREEN ENERGY CO] 6-K: Yingli Green Energy Preannounces Financial Results for Second
[Yingli Green Energy Preannounces Financial Results for Second Quarter 2012 BAODING, China; August 2, 2012 Yingli Green Energy Holding Company Limited (NYSE: YGE) (Yingli Green Energy or the Company), a leading solar energy company and one of the worlds largest vertically integrated photovoltaic (PV) manufacturers, which markets its products under the brand Yingli Solar, today preannounced its financial results]
OIIM [O2MICRO INTERNATIONAL] 6-K: (Original Filing)
[O2Micro Reports Second Quarter Results 2 ® GEORGE TOWN, Grand Cayman, Aug. 1, 2012 (GLOBE NEWSWIRE) -- O Financial Highlights for the Second Quarter ending June 30, 2012 2 O GAAP net loss was $10.9 million in Q2 2012. This compares to GAAP net income of $44,000 in the first quarter of 2012 and GAAP net income of $3.0 million]
OIIM [O2MICRO INTERNATIONAL] 6-K: O2Micro Reports Second Quarter Results 2 ® GEORGE
[O2Micro Reports Second Quarter Results 2 ® GEORGE TOWN, Grand Cayman, Aug. 1, 2012 (GLOBE NEWSWIRE) -- O Financial Highlights for the Second Quarter ending June 30, 2012 2 O GAAP net loss was $10.9 million in Q2 2012. This compares to GAAP net income of $44,000 in the first quarter of 2012 and GAAP net income of $3.0 million]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[BIOSTAR PHARMACEUTICALS, INC. RECEIVES APPROVAL FROM XIANYANG SFDA TO RESTART SALES OF ITS GEL CAPSULE DRUGS XIANYANG, China, August 3, 2012 - Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that on July 30, 2012, after]
BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. RECEIVES APPROVAL FROM XIANYANG SFDA
[BIOSTAR PHARMACEUTICALS, INC. RECEIVES APPROVAL FROM XIANYANG SFDA TO RESTART SALES OF ITS GEL CAPSULE DRUGS XIANYANG, China, August 3, 2012 - Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that on July 30, 2012, after]
